Compare FBK & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBK | AXGN |
|---|---|---|
| Founded | 1906 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2016 | 2013 |
| Metric | FBK | AXGN |
|---|---|---|
| Price | $53.33 | $55.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $63.38 | $59.27 |
| AVG Volume (30 Days) | 308.8K | ★ 1.9M |
| Earning Date | 10-13-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.43 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $12.93 | $28.93 |
| Revenue Next Year | $6.20 | $28.36 |
| P/E Ratio | $15.76 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $49.67 | $23.61 |
| 52 Week High | $62.66 | $59.72 |
| Indicator | FBK | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 68.22 |
| Support Level | $52.85 | $39.18 |
| Resistance Level | $53.56 | N/A |
| Average True Range (ATR) | 1.20 | 2.88 |
| MACD | -0.06 | 0.74 |
| Stochastic Oscillator | 4.90 | 64.86 |
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.